Cargando…
Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
Alopecia areata (AA) is a type of immune-mediated hair loss and is reported in patients with inflammatory bowel disease. This suggests that there might be a shared molecular pathway in the pathogenesis of AA and inflammatory bowel disease. In addition, tumor necrosis factor-alpha antagonists are als...
Autores principales: | Akiyama, Shintaro, Lin, Austin, Traboulsi, Cindy, Rubin, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613360/ https://www.ncbi.nlm.nih.gov/pubmed/34840997 http://dx.doi.org/10.14309/crj.0000000000000690 |
Ejemplares similares
-
Treatment of Resistant Alopecia areata with Tofacitinib
por: Avhad, Ganesh
Publicado: (2022) -
Resistant Alopecia Areata Treated with Tofacitinib
por: Sahay, Govind
Publicado: (2022) -
Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
por: Craiglow, Brittany G.
Publicado: (2018) -
Topical tofacitinib in treatment of alopecia areata
por: Ferreira, Sineida Berbert, et al.
Publicado: (2020) -
Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
por: Talty, Ronan, et al.
Publicado: (2022)